Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

66 recalls · Class I, newest first

Class I · High risk

Secret

Chemical contamination: presence of benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0246-2024
Class I · High risk

Secret

Chemical contamination: presence of benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0244-2024
Class I · High risk

Secret

Chemical contamination: presence of benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0243-2024
Class I · High risk

Secret

Chemical contamination: presence of benzene

Terminated Chemical / undeclared The Procter & Gamble Company NDC 37000-134-11 D-0242-2024
Class I · High risk

Old Spice

Chemical contamination: presence of benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0241-2024
Class I · High risk

Old Spice

Chemical contamination: presence of benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0240-2024
Class I · High risk

Old Spice

Chemical contamination: presence of benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0238-2024
Class I · High risk

Lotrimin AF

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0249-2022
Class I · High risk

Lotrimin Af

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0544-2 D-0248-2022
Class I · High risk

Lotrimin Af

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4140-2 D-0247-2022
Class I · High risk

Lotrimin Af

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-1272-2 D-0246-2022
Class I · High risk

365 SKINNY High Intensity Capsules

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.

Terminated Chemical / undeclared Je Dois Lavoir LLC D-0631-2022

Recalls by year